These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

55 related articles for article (PubMed ID: 2555960)

  • 21. [Effects of adrenergic stimulation on transmembrane transport of Na+ in patients with essential hypertension].
    Saitta A; Saitta MN; Messina A; Bonaiuto M; Cinquegrani M; Squadrito G; Castaldo M; Sardo A; Imbalzano E; Squadrito F
    Minerva Med; 1997; 88(7-8):275-82. PubMed ID: 9304069
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The effect of dietary sodium restriction on leucocyte sodium transport in normotensive subjects and in patients with essential hypertension.
    Poston L; Johnson VE; Gray HH; Hilton PJ; Markandu ND; MacGregor GA
    Klin Wochenschr; 1985; 63 Suppl 3():136-8. PubMed ID: 3999631
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Mechanisms of transmembrane cationic transport and essential arterial hypertension].
    Lacerna F; Panio R; Belfanti P; Di Benedetto M
    Minerva Cardioangiol; 1984; 32(7-8):457-62. PubMed ID: 6092999
    [No Abstract]   [Full Text] [Related]  

  • 24. Clinical and biochemical approach of a circulating Na+-pump inhibitor.
    Devynck MA; de The H; Pernollet MG; Cloix JF; Rosenfeld JB; Kamal LA; Meyer P
    J Physiol (Paris); 1984; 79(6):538-41. PubMed ID: 6152634
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Increase in plasma ouabainlike inhibitor of Na+, K+-ATPase with high sodium intake in patients with essential hypertension.
    Hasegawa T; Masugi F; Ogihara T; Kumahara Y
    J Clin Hypertens; 1987 Dec; 3(4):419-29. PubMed ID: 2839625
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Potassium, Na+-K+ pump inhibitor and low-renin hypertension.
    Haddy FJ
    Clin Invest Med; 1987 Nov; 10(6):547-54. PubMed ID: 2831002
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The relationship between insulin resistance and abnormality of cellular calcium metabolism in patients with essential hypertension.
    Fu Y; Wang S; Sun A; Lu Z; Li S
    Chin Med J (Engl); 1997 Nov; 110(11):891-2. PubMed ID: 9772426
    [No Abstract]   [Full Text] [Related]  

  • 28. Arterial blood pressure and plasma and body electrolytes in idiopathic hyperaldosteronism: a comparison with primary hyperaldosteronism (Conn's syndrome) and essential hypertension.
    Lasaridis A; Brown JJ; Davies DL; Fraser R; Robertson JI; Lever AF
    J Hypertens; 1984 Aug; 2(4):329-36. PubMed ID: 6530544
    [TBL] [Abstract][Full Text] [Related]  

  • 29. An Na+-K+-ATPase inhibitor which circulates in renal failure but not in essential hypertension.
    Stokes GS; Norris LA; Marwood JF; Monaghan JC; Caterson RJ
    Prog Biochem Pharmacol; 1988; 23():46-54. PubMed ID: 2847190
    [No Abstract]   [Full Text] [Related]  

  • 30. Endogenous digitalis-like compound in essential hypertension.
    Devynck MA; Pernollet MG; De The H; Rosenfeld JB; Meyer P
    Proc Eur Dial Transplant Assoc; 1983; 20():489-95. PubMed ID: 6318222
    [No Abstract]   [Full Text] [Related]  

  • 31. [Erythrocyte cation transport in arterial hypertension: interrelation with the renin-angiotensin-aldosterone system and the atrial natriuretic factor].
    Manunta P; Melis MG; Soro A; Pazzola A; Troffa C; Motzo S; Pala F; Madeddu P; Tonolo G; Glorioso N
    Boll Soc Ital Biol Sper; 1989 Nov; 65(11):1009-16. PubMed ID: 2560922
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Increased sodium, potassium cotransport activity in salt-sensitive essential hypertensive patients.
    Cacciafesta M; Ferri C; Carlomagno A; Piccirillo G; De Angelis C; Santucci A; Guidoni L; Luciani AM; Rosi A; Viti V
    J Hypertens Suppl; 1993 Dec; 11(5):S254-5. PubMed ID: 8158371
    [No Abstract]   [Full Text] [Related]  

  • 33. Evidence against a circulating ouabain-like transport inhibitor as a cause of increased red cell sodium in essential hypertension.
    Millar JA; Bramley PM; Paulin JM; Simpson FO
    J Hypertens Suppl; 1984 Dec; 2(3):S461-3. PubMed ID: 6599699
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Abnormally sustained aldosterone secretion during salt loading in patients with various forms of benign hypertension; relation to plasma renin activity.
    Collins RD; Weinberger MH; Dowdy AJ; Nokes GW; Gonzales CM; Luetscher JA
    J Clin Invest; 1970 Jul; 49(7):1415-26. PubMed ID: 4317384
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Methods of evaluating sodium and potassium flow through the erythrocyte membrane].
    Martín Vasallo P; Alonso Lancho MT; Chomón Barredo B; Tabernero JM; Battaner E
    Sangre (Barc); 1983; 28(6):703-10. PubMed ID: 6324400
    [No Abstract]   [Full Text] [Related]  

  • 36. [On the sodium to potassium ratio in daily urine of patients with arterial hypertension].
    Poseliugina OB
    Klin Med (Mosk); 2005; 83(8):57-9. PubMed ID: 16218366
    [TBL] [Abstract][Full Text] [Related]  

  • 37. 86Rubidium uptake in mononuclear leucocytes from young subjects at increased risk of developing essential hypertension.
    Nielsen JR; Johansen T; Pedersen KE; Klitgaard NA
    J Hypertens; 1988 Oct; 6(10):815-9. PubMed ID: 2848886
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Changes in sodium metabolism in essential hypertension patients].
    Elenkova A
    Vutr Boles; 1986; 25(3):103-8. PubMed ID: 3765573
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Increased rate of sodium-proton metabolism in erythrocytes of patients with occlusive thrombosis].
    Polikarpov SA; Orlov SN
    Biull Eksp Biol Med; 1991 Jan; 111(1):35-6. PubMed ID: 1647229
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Relation between a circulating inhibitor of sodium transport and arterial hypertension].
    Wardener HE; MacGregor GA
    Rev Esp Cardiol; 1983; 36(6):463-8. PubMed ID: 6326210
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.